23444 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Rishi Jaluria ★★★★☆ #683 | Outperform | $220.00→ $240.00+9.1% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Raimo Lenschow ★★★★☆ #369 | Overweight | $200.00→ $224.00+12.0% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Brad Reback ★★★☆☆ #1271 | Hold | $115.00→ $160.00+39.1% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Mark Moerdler ★★★☆☆ #1593 | Outperform | $216.00→ $238.00+10.2% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Michael Turrin ★★★★☆ #802 | Overweight | $215.00→ $225.00+4.7% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Keith Weiss ★★★★☆ #885 | Underweight | $145.00→ $180.00+24.1% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Steven Enders not yet tracked | Neutral | $139.00→ $201.00+44.6% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Matthew VanVliet ★★★★★ #201 | Overweight | $220.00→ $205.00-6.8% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Jason Celino ★★★★★ #269 | Overweight | $158.00→ $215.00+36.1% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Daniel Jester ★★★★★ #123 | Outperform | $182.00→ $230.00+26.4% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | firm only | Buy | $202.00→ $218.00+7.9% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Billy Fitzsimmons ★★★★★ #184 | Neutral | $145.00→ $190.00+31.0% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Scott Berg ★★★★★ #101 | Buy | $180.00→ $230.00+27.8% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Lucky Schreiner ★★★★★ #107 | Neutral | $135.00→ $190.00+40.7% |
|
Aug 29
00:47 UTC
|
WDAY
Workday
|
◎ Target | Derrick Wood ★★★★☆ #383 | Hold | $220.00→ $210.00-4.5% |
|
Aug 29
00:47 UTC
|
VEEV
Veeva Systems
|
◎ Target | Tyler Radke ★★★★★ #114 | Neutral | $190.00→ $273.00+43.7% |
|
Aug 29
00:47 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Michael Lasser ★★★☆☆ #1484 | Buy | $735.00→ $710.00-3.4% |
|
Aug 29
00:47 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Steven Zaccone ★★★☆☆ #1402 | Neutral | $560.00→ $580.00+3.6% |
|
Aug 29
00:47 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Kate McShane ★☆☆☆☆ #2872 | Buy | $648.00→ $667.00+2.9% |
|
Aug 29
00:47 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Adrienne Yih ★☆☆☆☆ #2841 | Overweight | $647.00→ $645.00-0.3% |
|
Aug 29
00:47 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Lorraine Hutchinson ★☆☆☆☆ #3051 | Buy | $685.00→ $650.00-5.1% |
|
Aug 29
00:47 UTC
|
ULTA
Ulta Beauty
|
◎ Target | Michael Baker ★★★★☆ #663 | Buy | $585.00→ $625.00+6.8% |
|
Aug 29
00:47 UTC
|
TOL
Toll Brothers
|
◎ Target | Jade Rahmani ★★★☆☆ #1419 | Outperform | $161.00→ $170.00+5.6% |
|
Aug 29
00:47 UTC
|
THFF
First Financial Corporation Indiana
|
◎ Target | Damon Delmonte ★★★★☆ #331 | Market Perform | $78.00→ $84.00+7.7% |
|
Aug 29
00:47 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Buy | C$185.00→ C$197.00+6.5% |
|
Aug 29
00:47 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Underweight | C$164.00→ C$167.00+1.8% |
|
Aug 29
00:47 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Sec→ r Outperform | C$180.00→ C$187.00+3.9% |
|
Aug 29
00:47 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Neutral | C$184.00→ C$187.00+1.6% |
|
Aug 29
00:47 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | Outperform | C$156.00→ C$173.00+10.9% |
|
Aug 29
00:47 UTC
|
TD
Toronto-Dominion Bank
|
◎ Target | firm only | C$159.00→ C$164.00+3.1% | |
|
Aug 29
00:47 UTC
|
TBBB
BBB Foods
|
◎ Target | Rodrigo Alcantara ★★★★★ #150 | Buy | $51.00→ $58.00+13.7% |
|
Aug 29
00:47 UTC
|
STNE
StoneCo
|
◎ Target | Kaio Prato not yet tracked | Buy | $15.00→ $13.00-13.3% |
|
Aug 29
00:47 UTC
|
STDN
Standard Nuclear
|
◎ Target | Christopher Dendrinos not yet tracked | Outperform | $11.00→ $13.00+18.2% |
|
Aug 29
00:47 UTC
|
SQM
Sociedad Quimica y Minera
|
◎ Target | Lucas Ferreira ★★★★☆ #935 | Neutral | $100.00→ $94.00-6.0% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Roger Boyd ★★★★★ #44 | Neutral | $16.00→ $24.00+50.0% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Shaul Eyal ★★★★★ #118 | Buy | $25.00→ $26.00+4.0% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Fatima Boolani ★★★★★ #95 | Neutral | $17.00→ $23.00+35.3% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Mike Cikos ★★★★★ #15 | Buy | $20.00→ $26.00+30.0% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Kingsley Crane ★★★★☆ #337 | Buy | $18.00→ $25.00+38.9% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Rustam Kanga not yet tracked | Market Outperform | $23.00→ $25.00+8.7% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Hamza Fodderwala not yet tracked | Equal Weight | $17.00→ $23.00+35.3% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Peter Weed ★★★★★ #18 | Outperform | $19.00→ $21.00+10.5% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Rob Owens ★★★★★ #17 | Neutral | $15.00→ $20.00+33.3% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Saket Kalia ★★★★★ #109 | Equal Weight | $22.00→ $23.00+4.5% |
|
Aug 29
00:47 UTC
|
S
SentinelOne
|
◎ Target | Patrick Colville ★★★★★ #66 | Sec→ r Outperform | $23.50→ $26.00+10.6% |
|
Aug 29
00:47 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Buy | C$307.00→ C$306.00-0.3% |
|
Aug 29
00:47 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Sec→ r Outperform | C$311.00→ C$312.00+0.3% |
|
Aug 29
00:47 UTC
|
RY
Royal Bank of Canada
|
◎ Target | firm only | Buy | C$310.00→ C$318.00+2.6% |
|
Aug 29
00:47 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Michael Yee ★★★★☆ #542 | Buy | $220.00→ $265.00+20.5% |
|
Aug 29
00:47 UTC
|
RVMD
Revolution Medicines
|
◎ Target | Michael Schmitz not yet tracked | Buy | $240.00→ $275.00+14.6% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.